肿瘤的分子生物学特征.ppt
- 配套讲稿:
如PPT文件的首页显示word图标,表示该PPT已包含配套word讲稿。双击word图标可打开word文档。
- 特殊限制:
部分文档作品中含有的国旗、国徽等图片,仅作为作品整体效果示例展示,禁止商用。设计者仅对作品中独创性部分享有著作权。
- 关 键 词:
- 肿瘤 分子生物学 特征
- 资源描述:
-
,单击此处编辑母版标题样式,单击此处编辑母版文本样式,第二级,第三级,第四级,第五级,单击此处编辑母版标题样式,单击此处编辑母版文本样式,第二级,第三级,第四级,第五级,*,Molecular Cell Biology of Tumor,Basic Concepts of Tumor Biology,What Must Happen For Tumors To Develop,What causes Cancer?,Analytical Approaches,Therapies for Cancer,A Cellular and Molecular Foundation for Understanding Cancer,A survey course of cancer biology including,tumor pathology,initiation,progression and metastasis,genetic instability,DNA damage and repair,cell cycle control,oncogenes and tumor suppressor genes and the immune response,.,Basic Concepts of Tumor Biology,Cancer Incidence and Death Rate,Initiation,Promotion,and Progression,Events in metastasis.,MOLECULAR CARCINOGENESIS,1044-CH,CHEMICAL,VIRUS,R,A,D,I,A,T,I,O,N,Body Surface,Deactivation,Excretion,Activation,NORMAL,CELL,Inhibition,Defects in Terminal Differentiation,Defects in Growth Control,Resistance to Cytotoxicity,Defects in Programmed Cell Death,Genetic,Change,Selective,Clonal,Expansion,Genetic,Change,Genetic,Change,INITIATED,CELL,PRE-,NEOPLASTIC,LESION,MALIGNANT,TUMOR,CLINICAL,CANCER,CANCER,METASTASIS,Genetic,Change,Activation of Proto-Oncogenes,Inactivation of Tumor Suppressor Genes,Inactivation of Genomic Stability Genes,Nucleus,The Hallmarks of Cancer,General Information,Derangements in the cell cycle-uncontrolled cell division-tumor growth,Links between cell cycle and cancer:more and more discovered all of the time,Codes for a protein that turns on the production of another protein that blocks cdk2 and other cdks,particularly affecting cyclin D1 interaction with these cdks.Therefore if a tumor supressor(p53)malfunctions this could lead to tumor progression.,General Information(2),In general,Cancer-loss of regulated cell growth,Cancer cells are monoclonal,derived from cells that have undergon neoplastic transformation,Characteristics of cancer cells,vascularized(develop own blood supply),invasive(secrete degradatory enzymes)invade surrounding tissue,metastasize(cells dislodge from origional tumor and establish new tumors at far away sites),General Information(3),Causes of neoblastic transformation,Gene translocation EX:Philly chromosome:piece of chromosome 22 transfers to chromosome 9),Viruses especially retroviruses:RNA-DNA inserts in host cell genome,Environmental carcinogens(50-90%)of all human cncers,most require conversion of procarcinogen-ultimate carcinogen,act by producing genetic mutations,General Information,In order to actually cause cancer any of the above must be in areas of the genome that affect the cell cycle,Genetic basis of Neoplasia,Oncogenes:src,myc,ras(c-src,c-myc,c-ras),all have been associated with cancers and all have potential roles in the control of the cell cycle,Dosage effect,Gene mutation,Tumor suppressor genes:Rb,p53,apc,What causes Cancer?Genetic mutations,The Oncogene,A Key Factor in the Development of Cancer,Mechanisms of Proto-oncogene activation,1.Mutations,:,*Point mutations/deletions/insertions -most characterized in human trs,frequent in Ras*Causes constitutive activation of the signal transducing function of Ras protein,2.Gene amplification,Results from several rounds of unscheduled DNA synthesis occurring during a single cell cycle,-HSR,DM Her2 Breast cacinoma,n-myc neuroblastoma,3.,Chromosomal re-arrangement,*,chromosomal translocations;inversions,*,Gene activation,-,transcriptional activation of Proto-oncogenes,eg.follicular lymphoma,t,(14:18)Bcl2,Burkitts lymphoma,t,(8:14)c-myc,*,Gene fusion,:codes for chimeric protein,eg.CML,t,(9:22)BCR/Abl.,APML,t(,15:17)PML/Rar,Tumorgenesis -,?,Definition for:Oncogene,Literally,a gene that causes cancer.Proto-oncogenes are a class of genes which code for gene products having critical roles in cell growth and signalling.If activated by a,point mutation,or,amplification,a proto-oncogene becomes an oncogene.,Initiation,Promotion,Progression,Genetic,(,Oncogenes/tr suppressor genes,),Mitogenesis,Immune surveillance,Angiogenesis,Epigenetic,(,clonal expansion,),Function-Carcinogenesis,Oncogenes,Gene encoding proteins that is essential for the initiation,promotion and progression of the malignant state,100 different oncogenes,discovered as the transforming genes of RNA tumour viruses,Proto-oncogene,counterpart of viral-oncogene,-normal cellular genes which encodes proteins to regulate cellular response to external stimuli that controls cellular proliferation and differentiation.,-activated by mutation,-nomenclature,Classification of oncogenes,1.Growth factors-sis,ist,2.Growth factor receptors(RTK)-erb B2,fms,3.Non receptor tyrosine kinases-abl,src,4.GTP binding-ras,5.DNA damage repair-ATM,MSH2,B cl2,6.Serine/threonine kinases,7.Transcription factors-Myc,fos,jun,8.Misc-cell surface APC/DCC,Types of proteins encodes by oncogenes,Tumour suppressor genes:,*recessive genotype,-exception p27kip1,*Controls cell proliferation,*20 tumor suppressor genes,*,Inherited cancers,:Colon cancer,Retinoblastoma,Wilms tr,breast cancer Neurofibromatosis,Li-Fraumeni syndrome,Xeroderma pigmentosum,Suppression of Oncogene,To suppress oncogene expression:,(1)transcriptional level:deliver a transcriptional repressor acting on the promoter of oncogene,e.g.adenovirus E1A gene products can repress the neu promoter or truncation protein of SV40 Large T antigen,(2)post-transcriptional level:deliver ribozyme,antisense,dominant negative molecule.e.g.ribozyme for activated ras(point mutation),Cyclins/cyclin dependent kinases(cdk),-key regulators of cell cycle,-cyclin/cdk activated by phosphorylation,*9 cdks(cdk 1-cdk 9);15 cyclins(A-T),*G1,cyclins-cyclins C,D,E,*G2/M,cyclins-cyclins A,B,F,Cyclin dependent kinase inhibitors(CKIS),*INK4(,in,hibitor of cd,k4,)-p16,INK4a,p15,INK4c,P19,INK4d,*Kinase inhibitor proteins-P21,waf,p27,Kip1,p57,Kip2,*inhibits cyclin E/cdk2 and cyclin A/cdk2,GROWTH FACTOR,RECEPTOR,TYROSINE,KINASE,GRB-2,SOS,RAS,RAF,MAPKK,MEMBRANE,MAPK,Dimerization;,autophosphorylation,Interaction of,signaling molecules,Activation of,“downstream”,kinases,JAK,STAT,P,NUCLEUS,MAPK,Phosphorylation of transcription factors,STAT,GENE EXPRESSION,CYTOPLASM,P,P,P,P,P,P,P,P,P,P,P,P,P,P,P,P,P,P,P,P,P,fos,jun,myc,SIGNAL TRANSDUCTION,Iressa,Gleevec,FTIs,BAY 43-9006,Dasatinib,AVASTIN,Steps in the activation of Ras by RTKs,.,Ras-GEF,Raf,SH2 binds RTK,SH3 binds SOS,c-fos,c-jun,Cell proliferation,Raf is a PK that triggers MAP-K pathway,Steps in the MAP kinase cascade,MAPK enter nucleus and activates transcription factors(Elk-1),Elk-1 binds to promoter of several genes,e.g.,c-fos,c-jun,Protein products(Fos,Jun)interact to form the AP-1 transcription,factor that activates other genes involved in,cell proliferation,RAS,1),Superfamily of small GTPases.Involved in signal transduction from the plasma membrane to the nucleus.,2)The signal transduction pathway induces a kinase cascade and ultimately activation of the MAP kinase pathway.,See figure 15.26,3)Activated ras binds to kinases(Raf)which become active and phosphorylate other kinases,R,S,G,GTP,GDP,Y,P,Raf(MAPKKK),MAPKK,MAPK,Fos/Jun activation,Cyclin D1,G,GRB2 adaptor mol,.,S,SOS,Ras GAP,Ras-G protein system,Cell death-necrosis/apoptosis,Regulation of Apoptosis,*Genetic-,p53,Bcl2/Bax,*Caspases,*Death receptors-,Fas,TNFR,*Granzyme system,Apoptosis,2 pathways,-Caspases Cytochrome C,Caspases-cysteine proteases,13 caspases,Pro caspases(zymogens),Caspases -2 groups,initiator caspases-2,8,9,10,effector caspases-3,6,7,TNF,TNFRI,FLICE,FADD,Caspase 3,TRADD,Fas/FasL,Caspase 8,Bid,tBid,Mitochondria,Apoptosis,Bcl2,Apoptosis pathways,N,Bcl2,Cyt C,Apaf 1,Caspase 9,Caspase 3,p53,Bax,Apoptosis,Mitochondria,.,.,AIF,nucleus,Cyt C,Apoptotic,signal,Apoptosis pathways,NEOPLASIA,molecular basis,GROWTH PROMOTING,PROTO-ONCOGENES,GROWTH INHIBITING,CANCER SUPPRESSOR GENES,ANTI-ONCOGENES,-,GENES REGULATING CELL DEATH,APOPTOSIS,-Carcinogenesis is a multistep process at both at the,phenotypic and genetic level,Tumorgenesis -,Protein Action,What Must Happen For Tumors To Develop*,Dysregulation of Cell Cycle,Alteration of cell cycle genes,Alteration in DNA methylation and other modifications,(Epigenetic Changes),Mutations,Oncogene Activation,Tumor Suppressor Inactivation,(Genetic Alterations,),*,Aint no musts in Cancer Biology,What Must Happen For Tumors To Develop-2,“,Immortalization”must occur,Genetic and Epigenetic alterations are involved here as well,Apoptosis is inhibited,(a hallmark of nearly all tumors),Telomeres,are,NOT,shortened due to reactivation of telomerase;“senescence”pathways are affected,Proto-oncogenes and suppressors involved to be discussed in Cancer Cell Signaling,What Must Happen For Tumors To Develop-3,Genetic instability,develops,Alterations in DNA repair genes occur,“Mutator”phenotypes are common,Growing tumors require,Angiogenesis,How many“new”vessels form is controversial,Whether lymphangiogenesis signals lymph node metastasis is also controversial,What Must Happen For Tumors To Develop-4,Cell-Extracellular Matrix Interactions,are altered,Changes in structural proteins(e.g,integrins,Changes in enzymes(signaling enzymes,proteases,etc.,Not as relevant to hematologic tumors,Result:Increased,Migration,Invasion,i.e.critical steps in metastasis,Increased resistance to,Anoikis,(Greek for homelessness),What must happen for tumors to develop-5,Alterations in microenvironment must occur,Endothelial Cells;circulating endothelial cells;fibroblasts,etc etc are different in the tumor microenvironment than in the“normal”organ,Angiogenesis,Angiogenesis,Local degradation of basement membrane,Directional migration,invasion,Endothelial cell proliferation,Capillary tube morphogenesis,Coalescence of capillaries,Vascular pruning,Angiogenesis,Proangiogenic,-Angiogenic growth factors,VEGF,FGF,TNF,HGF,IGF,TGF,Proliferin,Anti angiogenetic-,Thrombospondin -1,2,Angiostatin,Endostatin,Platelet factor 4,Integrins in angiogenesis,Molecular Biology of Angiogenesis,The interplay between tumor and stromal cells also dictates tumor metastasis,Stromal cells acquire mutations similar to tumor cells-How?Completely Unknown,There is a molecular dance between tumor cells/endothelial cells and other cells that promotes metastasis,There is considerable interest in targeting endothelial cells by therapeutic treatments and arguments that these cells ARE the targets,Autocrine Regulation by VEGF in Tumor Cells?,VEGF-R,Src*,FAK,Increased tumor cell migration;,Increased VEGF expression,tumor cell,EGF-R,C-Met,TGF,a,HGF,Src*,VEGF,VEGF,Roles of Src and VEGF in Endothelial Cells and Tumor Cells,Src*,VEGF-R,VE cadherin,Increased EC permeability;,Increased migration,VEGF,Increased tumor cell migration;,Increased VEGF expression,endothelial cell,VEGF-R,Src*,FAK,tumor cell,Spontaneous metastasis is impaired in Src-/-mice(Cheresh),Will Src inhibitors,Have greatest,Efficacy for,Metastasis-inhibition?,Low Src;,Low VEGF,A,Low Src activity,Low permeability,B,Basement membrane,C,Increased VEGF,High Src activity,High permeability,D,=,VEGF,Src*,VEGF-R,VE cadherin,Increased EC permeability,E,Src activation in EC cells,Src Activation in Tumor and Host Cells,Src Cycle?,Implication:Src,Activity in Tumor,Cells Effects Src,Activity in Endothelial Cells,Src Activation in Tumor,Via AOR(Any Old Receptor,),Inflammation and tumor progression,General properties of metastatic tumor cells,Produce elevated levels of cell-surface receptors specific for the proteins and polysarrharides composing basal laminae(collagens,proteoglycans,and glycosaminoglycans),Secrete enzymes that digest these proteins,Secrete a protease called plasminogen activator(plasminogen converted to plasmin)digestion of basal lamina,Secrete factors that stimulate angiogenesis,bFGF,TGF,VEGF(vascular endothelial growth factor),Therapy:inhibit antiogenesis:endostatin.,Question:how proliferative are blood vesssels in adults?,.,DNA Array,Proteomics,Analytical Approaches,in Molecular Biology of Cancer,Pathway specific cDNA arrays,Science,Vol 259,Issue 5091,84-87Copyright 1993 by American Association for the Advancement of ScienceRegulation,of,the,human,hsp70,promoter,by,p53,SN Ag,of,f,J Hou,DI Linzer,and B Wu,Department of Biochemistry,Molecular Biology,and Cell Biology,Northwestern University,Evanston,IL 60208.,The tumor suppressor p53 is a nuclear phosphoprotein with characteristics of a transcription factor.It displays sequence-specific DNA binding,contains a potent transactivation domain,and has been implicated as both a transcriptional activator and a repressor.Transcription of the human hsp70 gene is stimulated by adenovirus E1a protein.This E1a transactivation of the hsp70 promoter is mediated by CCAAT binding factor(CBF).It is demonstrated here that p53 both represses transcription from the human hsp70 promoter and also interacts with CBF.Thus,the repression of the hsp70 promoter by p53 may be mediated by direct protein-protein interaction with CBF.These results suggest that protein-protein interaction between p53 and specific transcription factors may be an additional mechanism by which p53 regulates gene expression.,2,D gel electophoresis:IEF,then SDS-PAGE,Therapies for Cancer,Traditional Treatments,Chemotherapy,Radiotherapy,Surgery,New Therapies for Cancer,Immunotherapy,Gene Therapy,Antisense,Oncoproteins as drug targets,Anti-angiogenetic drugs,Treatment,1.Growth Factor receptors,Her2 -trastuzumab,(monoclonal antibody,against Her2),2.Cell cycle check point control,i)cdk inhibitors,ii)reactivation of p16,ink4,iii)replacement of p16,ink4,iv)G2 check point inhibitors,v)inhibition of ATM kinases,ANTISENSE OLIGONUCLEOTIDE THERAPY,protein,N,DNA,Antisense DNA,No protein,mRNA,Cytoplasm,Promote tumor cell apoptosis,1.Gene therapy-p53,2.Activation of caspases,3.Bcl2 inhibition,4.Peptides mimicking Bax,5.Death signals,6.NF-kB,Angiogenesis inhibitors,1.Induction of vascular discontinuity,batimastat,marimastat,2.Endothelial locomotion,IFN,suramin,linomide,3.Endothelial cell proliferation,angiostatin,4.Endothelial sprouting,cyclosporine,Inhibitors of Metastasis,1.Cell detachment,-,E cadherin,2.Adhesion -,RGD peptide,ASDN,Tamoxifen,3.Invasion-,matrix metalloproteinase inhibitors,marimastat,AG3340,4.Motility-,paclitaxel,5.Signal transduction-,STI571,herbimycin A,6.Angiogenesis,The end!,展开阅读全文

咨信网声明:本文档由用户上传并分享,仅供学习交流、研究之用,未经授权,严禁复制、发行、汇编、翻译或网络传播等,侵权必究。
咨信网小贴示:
1、浏览或下载可查看了解,请点击【咨信网告知】。
2、下载文件中如有侵权或不适当内容,将立即纠正。
3、如果因为网速或其他原因下载失败请重新下载,重复下载[60天内]不扣币。
4、开具发票登录电脑端申请,请点击【索取发票】。
咨信网客服组:【微信客服】
1、浏览或下载可查看了解,请点击【咨信网告知】。
2、下载文件中如有侵权或不适当内容,将立即纠正。
3、如果因为网速或其他原因下载失败请重新下载,重复下载[60天内]不扣币。
4、开具发票登录电脑端申请,请点击【索取发票】。
咨信网客服组:【微信客服】


肿瘤的分子生物学特征.ppt
















自信AI助手














微信客服
客服QQ
发送邮件
意见反馈



链接地址:https://www.zixin.com.cn/doc/12222959.html